SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001178913-20-000347
Filing Date
2020-02-11
Accepted
2020-02-11 12:16:33
Documents
1
Group Members
MOSHE ARKINSPHERA GLOBAL HEALTHCARE GP LTD.SPHERA GLOBAL HEALTHCARE MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk2023963.htm SC 13G/A 98236
  Complete submission text file 0001178913-20-000347.txt   100110
Mailing Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G/A

Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Subject) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-88883 | Film No.: 20595419
SIC: 2834 Pharmaceutical Preparations